Lars Bruening, CEO, Bayer UK & Ireland

After spending five years heading market access globally, Lars Bruening returned to a country manager role in the UK; he shares with us his thoughts on Brexit while also highlighting exciting Phase III developments and introducing the new Baylab opened by Bayer in Reading (near London).  
It is this kind of contribution that has accelerated us to number five on the pharma UK rankings but quite frankly, working hard every day to continuously help change lives for the better and seeing that in practice, is far more satisfying than a number
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:

Related Interviews

Latest Report